Dr. Anand Srivastava received Bachelors in Science (B.Sc.) from University of Delhi, Delhi, and Masters of Science (M.Sc-Biotechnology) from the Allahabad University, Allahabad, India. He did Ph.D. from Jawaharlal University (JNU) working at International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India. He then worked at Institut Pasteur, Paris (2008-2011) and Institut National de Transfusion Sanguine, Paris (2011-2012) as a Post-doctoral Fellow. He joined National Institute of Animal Biotechnology (NIAB) in 2013.
Selected awards, honors and fellowships:
Membership of Societies:
Area of Specialization: Host parasite interaction, Proteomics, Drug discovery, Yeast 2 hybrid, Phage display
Our group focuses on the following research areas:
1. Understanding of tick biology and developing tick control measures
Ticks are blood-feeding ectoparasites that pose a serious threat to human and animal health by transmitting varies infectious pathogens, which causes diseases such as theileriosis, Lyme disease, anaplasmosis, and babesiosis. Their ability to evade host immune responses and develop resistance to synthetic acaricides makes control efforts increasingly challenging. Our research focuses on two key approaches to tackle this issue. First, at the tick-host interface, protease cascades play a crucial role in host defenses, including coagulation, platelet aggregation, and complement activation. We hypothesize that ticks evade the immune response by secreting protease inhibitors (PIs), which could hold therapeutic potential. In our study, we identified putative PIs in ticks. We discovered a serpin protein from Hyalomma anatolicum, as a host complement modulator (https://doi.org/10.1016/j.jbc.2024.107684). This could serve as a target for novel vaccines and therapeutics development. Second, we explore Indian medicinal plants to identify bioactive compounds with acaricidal properties, offering a sustainable alternative to chemical treatments. We developed a phytoformulation using Indian medicinal plants to specifically control Rhipicephalus microplus and successfully obtained a patent for its efficacy. By integrating molecular biology, analytical techniques, and in silico methods, we aim to develop sustainable and effective solutions for managing tick populations and reducing their impact on livestock and public health.
2. Understanding molecular mechanism of induction cancerous like phenotype in the host cells by Theileria annulata parasite and repurposing of drugs for Theileriosis
A disease called “theileriosis” in ruminants is caused by the apicomplexan parasite Theileria. This is a unique parasite as it causes an unchecked proliferation of the leucocytes, thus leading to a cancer-like phenotype in the host cells. The untreated cattle die in 3-4 weeks. The present vaccine and drug molecules have their own limitations. Further, there are reports of the development of resistance in these parasites to the commonly used drug Buparaquone. Hence, we are in the quest of developing better interventions in the form of vaccine and drug molecules for curing theileriosis. In order to develop newer drug candidates, my research group is interested in the identification of a key molecule(s) from the parasite, which is essential for the transformation of the host cells. Further, we are on a quest to identify various surface molecules that can be targeted for vaccine development. Also, we aim to repurpose drugs as anti-theilerial.
3. Exploring the factor of Staphylococcus aureus related to AMR, biofilm and virulence and identification new molecules to cure S. aureus infection.
Staphylococcus aureus is a prevalent zoonotic pathogen. It has clinical relevance in conditions like mastitis, pneumonia, wound, and bloodstream infections. S. aureus gains significant survival advantages due to its rapid adaptation proficiency to antibiotics and biofilm formation, leading to antimicrobial resistance (AMR).
Our goal is to Identify and characterize biofilm and AMR related factors of S. aureus which are crucial for basic and translational research. We use CRISPR based technologies for targeted gene mutation and silencing to validate the role of putative factors in AMR and biofilm formation.
Also, at present, the best strategy to tackle these conditions include high doses of antibacterial. However, the clinical cure rate still remains low. Natural product-based antimicrobial and antibiofilm agents offer potential for developing new therapies and strategies to combat AMR and biofilm-related conditions. Compounds from natural sources may serve as adjunctive therapy alongside conventional antibiotics to augment their effectiveness and mitigate the risk of antibiotic resistance. Our aim is to identify and characterize potential plant based antibiofilm and AMR resensitizing agents and explore their mechanism of action.
36. Dorin-Semblat D, Semblat J-P, Hamelin R, Srivastava A, Tetard M, Matesic G, Doerig C, Gamain B. (2025) Casein Kinases 2-dependent phosphorylation of the placental ligand VAR2CSA regulates Plasmodium falciparum-infected erythrocytes cytoadhesion. PLoS Pathog 21(1): e1012861. DOI: https://doi.org/10.1371/journal.ppat.1012861
35. Deval S, Nathan VS, Venkataraman S, Rao PL, Kar PP, Srivastava A, Subbiah M* Accessory viral protein, V, of Newcastle Disease Virus binds dsRNA to facilitate immune evasion. VirusDis. (2025). DOI: https://doi.org/10.1007/s13337-024-00908-4
34. Dhabale AR, Jadhav ND, Srivastava A, Vijay M, Kumar S, Sharma AK, Gudewar JG, Narawade MR, Jadhao SG, Chepte SD, Chigure GM Influence of extraction method of Carica papaya seeds and Chrysanthemum roseum leaves on the acaricidal property against Rhipicephalus microplus. Int J Trop Insect Sci 45, 137–143 (2025). DOI: https://doi.org/10.1007/s42690-024-01412-4
33. Mood R, Krishnagaanth M, Vijay M, Srivastava A*. The serine protease inhibitor HAMpin-1 produced by the ectoparasite Hyalomma anatolicum salivary gland modulates the host complement system. JBC Volume 300, Issue 9, September 2024, 107684 (*corresponding author). DOI: https://doi.org/10.1016/j.jbc.2024.107684
32. Khating S, Jadhav N, Vijay M, Sharma AK, Srivastava A, Jadhao S, Kumar S, Kalwaghe S, Siddiqui MFMF, Narawade M, Dhabale A, Chigure G. Current profile of phenotypic pyrethroid resistance in Rhipicephalus microplus (Acari: Ixodidae) populations sampled from Marathwada region of Maharashtra state, India. Parasitol Res. 2024 Jul 22;123(7):282. PMID: 39037590. DOI: https://doi.org/10.1007/s00436-024-08306-x
31. Kar PP, Araveti PB, Saxena K, Borah A, Sijwali S, Srivastava A*. Cimicifugin, a broad-spectrum inhibitor of Theileria annulata and Plasmodium falciparum CDK7. Antimicrob Agents Chemother, 0:e00440-24. (*corresponding author). DOI: https://doi.org/10.1128/aac.00440-24
2022
30. Araveti PB, Kar PP, Kuriakose A, Sanju A, Kumar KA, Srivastava A. Identification of a novel interaction between Theileria Prohibitin (TaPHB-1) and bovine RUVBL-1. Microbiology Spectrum. 2023 10.1128/spectrum.02502-22
29. Putty K, Rao PL, Vishweshwar Kumar Ganji, Devasmita Dutta, Subhajit Mondal, Nagendra Hegde, Anand Srivastava, Madhuri Subbiah. The first report on the complete genome sequence of Lumpy skin disease virus in India. 2023 Virus gene
28. Kar, P.P., Araveti, P.B., Kuriakose, A. Srivastava A. Design of a multi-epitope protein as a subunit vaccine against lumpy skin disease using an immunoinformatics approach. Sci Rep 12, 19411 (2022). https://doi.org/10.1038/s41598-022-23272-z
27. Kar PP, Araveti PB, Srivastava A. Deciphering the kinome of Theileria annulata for identification of drug targets and anti-theilerial drug. Ticks Tick Borne Dis. 2022 Sep 29;13(6):102049.
doi: 10.1016/j.ttbdis.2022.102049. PMID: 36215767.
26. Singh D, Patri S, Narahari V, Segireddy RR, Dey S, Saurabh A, Macha V, Prabhu NP, Srivastava A, Kolli SK, Kota AK. A Conserved Plasmodium Structural Integrity Maintenance Protein (SIMP) is associated with sporozoite membrane and is essential for maintaining shape and infectivity. Molecular microbiology 17 March 2022 https://doi.org/10.1111/mmi.14894
25. Araveti PB, Vijay M, Kar PP, Varunan S, Srivastava A. MMV560185 from Pathogen box induces extrinsic pathway of apoptosis in Theileria annulata infected bovine leucocytes International Journal for Parasitology: Drugs and Drug Resistance Volume 18, April 2022, Pages 20-31
https://doi.org/10.1016/j.ijpddr.2021.12.003
2021
24. Gulla S, Reddy VC, Araveti PB, Lomadad D, Srivastava A, ReddyaKakarl MC, Reddy R. Synthesis of titanium nanotubes conjugated with quercetin and its in-vivo anti-tumor activity against skin cancer. Journal of Molecular Structure (2021) Volume 1249, 5 February 2022, 131556 https://doi.org/10.1016/j.molstruc.2021.131556
23. Acaricidal activity of Annona squamosa L. seeds extracts against cattle tick, Rhipicephalus microplus. Jadhav ND, Rajurkar SR, Vijay M, Narladkar BW, Srivastava A, Mamde CS, Vaidya MS, Chigure GM, Kumar S. International Journal of Tropical Insect Science (2021). https://doi.org/10.1007/s42690-021-00630-4
22. Gulla S, Lomada D, Araveti PB, Srivastava A, Murikinati MK, Reddy KR, Inamuddin, Reddy MC & Altalhi T. Titanium dioxide nanotubes conjugated with quercetin function as an effective anticancer agent by inducing apoptosis in melanoma cells. Journal of Nanostructure in Chemistry (2021). https://doi.org/10.1007/s40097-021-00396-8
2019
21. Araveti, P.B., Srivastava, A. Curcumin induced oxidative stress causes autophagy and apoptosis in bovine leucocytes transformed by Theileria annulata. Cell Death Discov. 5, 100 (2019). https://doi.org/10.1038/s41420-019-0180-8 ( *corresponding author)
20. Gangnard S, Chêne A, Dechavanne S, Srivastava A, Avril M , Smith JD. VAR2CSA binding phenotype has ancient origin and arose before Plasmodium falciparum crossed to humans: implications in placental malaria vaccine design Scientific reports 9, 16978 (2019). https://doi.org/10.1038/s41598-019-53334-8
19. Dorin-Semblat D, Tétard M, Claës A, Semblat JP, Dechavanne S, Fourati Z, Hamelin R, Armand F, Matesic G, Nunes-Silva S, Srivastava A, Gangnard S, Lopez-Rubio JJ, Moniatte M, Doerig C, Scherf A, Gamain B. Phosphorylation of the VAR2CSA extracellular region is associated with enhanced adhesive properties to the placental receptor CSA Plos Biology 2019 https://doi.org/10.1371/journal.pbio.3000308
2018
18. PP Kar, A Srivastava* Immuno-informatics Analysis to Identify Novel Vaccine Candidates and Design of a Multi-Epitope Based Vaccine Candidate Against Theileria parasites Frontiers in Immunology 9 2018 ( * corresponding author) DOI=10.3389/fimmu.2018.02213
17. Chêne A, Gangnard S, Dechavanne C, Dechavanne S, Srivastava A, Tétard M, Hundt S, Leroy O, Havelange N, Viebig NK and Gamain B Down-selection of the VAR2CSA DBL1-2 expressed in E. coli as a lead antigen for placental malaria vaccine development 3(28) 2018 NPJ Vaccine https://doi.org/10.1038/s41541-018-0064-6
2017
16. Anilkumar K, Reddy GV, Azad R, Yarla NS, Dharmapuri G, Srivastava A, Kamal MA, and Reddanna Pallu. Evaluation of Anti-Inflammatory Properties of Isoorientin Isolated from Tubers of Pueraria tuberosa. Oxidative Medicine and Cellular Longevity Volume 2017: 2017:5498054. | https://doi.org/10.1155/2017/5498054
2016
15. de Moraes LV, Dechavanne S, Sousa PM, Barateiro A, Cunha SF, Nunes-Silva S, Lima FA, Murillo O, Marinho CR, Gangnard S, Srivastava A, Braks JA, Janse CJ, Gamain B, Franke-Fayard B, Penha-Gonçalves C. A Murine Model for Pre-Clinical Studies on Var2CSA-Mediated Pathology Associated to Malaria in Pregnancy. Infect Immun. 2016 Apr 4. pii: IAI.01207-15.
2015
14. Gangnard S, Lewit-Bentley A, Dechavanne S, Srivastava A, Amirat F, Bentley GA, Gamain B. Structure of the DBL3X-DBL4ε region of the VAR2CSA placental malaria vaccine candidate: insight into DBL domain interactions. Sci Rep. 2015 Oct 9;5:14868.
13. Dechavanne S, Srivastava A, Gangnard S, Nunes-silva S, Dechavanne C, Fievet N, Deloron P, Chêne A, Gamain B The parity-dependent recognition of the DBL1X-3X suggests an important role of the VAR2CSA high affinity CSA-binding region in the development of the humoral response against placental malaria. Infect Immun. 2015 Mar 30. pii: IAI.03116-14
2014
12. Gullingsrud J, Milman N, Saveria T, Chesnokov O, Williamson K, Srivastava A, Gamain B, Duffy PE, Oleinikov AV. High-Throughput Screening Platform Identifies Small Molecules That Prevent Sequestration of Plasmodium falciparum-Infected Erythrocytes. J Infect Dis. 2014 Oct 29. pii: jiu589
2011
11. Srivastava A, Gangnard S, Dechavanne S, Amirat F, BentleyGA, Bentley GA and Gamain B Var2CSA minimal CSA binding region is located within the N-terminal region. PLoS One 2011 May 11, 6(5):e20270.
10. Rathore S, Jain S, Sinha D, Gupta M, Asad M, Srivastava A, Narayanan MS, Ramasamy G, Chauhan VS, Gupta D, and Mohmmed A. Disruption of a mitochondrial protease machinery in Plasmodium falciparum is an intrinsic signal for parasite cell death. Cell Death and Disease 2011 Nov 24;2:e231
9. Avril M, Hathaway MJ, Srivastava A, Dechavanne S, Hommel M, Beeson JG, Smith JD, Gamain B. Antibodies to a Full-Length VAR2CSA Immunogen Are Broadly Strain-Transcendent but Do Not Cross-Inhibit Different Placental-Type Parasite Isolates. PLoS ONE 2011 Feb 4;6(2):e16622
8. Pandey A, Srivastava A, Pandey A. Acidithiobacillus ferrooxidans: A bioleaching bacteria for better iron(II) oxidation ability International Journal of Innovation in biological and Chemical Sciences, 1, 32-37, 2011.
2010
7. Srivastava A, Singh S, Dhawan S, Alam MM, Mohmmed A, Chitnis CE. (contributed to cover pager image) Localization of Apical Sushi Protein in Plasmodium falciparum merozoites. Mol Biochem Parasitol. 2010 Nov;174(1):66-9
6. Srivastava A, Gangnard S, Round A, Dechavanne S, Juillerat A, Raynal B, Faure G, Baron B, Ramboarina S, Singh SK, Belrhali H, England P, Lewit-Bentley A, Scherf A, Bentley GA, Gamain B. Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSA. PNAS 2010 Mar 16;107(11):4884-9
2009
5. Mayor A, Rovira-Vallbona E, Srivastava A, Sharma SK, Pati SS, Puyol L, Quinto L, Bassat Q, Machevo S, Mandomando I, Chauhan VS, Alonso PL, Chitnis CE. Functional and immunological characterization of a Duffy Binding-Like alph1 a domain from Plasmodium falciparum-erythrocyte membrane protein-1 that mediates resetting. Infect Immun. 2009 Sep;77(9):3857-63
2008
4. Korde R, Bhardwaj A, Singh R, Srivastava A, Chauhan VS, Bhatnagar RK, Malhotra P. A prodomain peptide of plasmodium falciparum cysteine protease (falcipain-2) inhibits malaria parasite development. J Med Chem. 2008 Jun 12;51(11):3116-23.
2007
3. Sivakumar S, Rajagopal R, Raja Venkatesh G, Srivastava A, Bhatnagar RK. Knockdown of aminopeptidase-N from Helicoverpa armigera larvae and in transfected SF21 cells by RNA interference reveals its functional interaction with Bacillus thuringiensis insecticidal protein Cry1Ac. J Biol Chem. 2007 Mar 9;282(10):7312-9
2004
2. Kulkarni KA, Srivastava A, Mitra N, Sharon N, Surolia A, Vijayan M, Suguna K. Effect of glycosylation on the structure of Erythrina corallodendron lectin. Proteins. 2004 Sep 1; 56(4):821-7.
1. Jeyaprakash AA, Srivastav A, Surolia A, Vijayan M. Structural basis for the carbohydrate specificities of artocarpin: variation in the length of a loop as a strategy for generating ligand specificity. J Mol Biol. 2004 May 7; 338(4):757-70.
Book Chapter
1. Anand Srivastava, Yves Durocher, and Benoit Gamain. Expressing full length PfEMP1 proteins in the HEK293 expression system, Malaria: Methods and Protocols, Series Methods in Molecular biology. Ed Robert Menard 2nd ed. 2013;923:307-19. Humana Press (ISBN 978-1-62703-025-0)
DOI: https://doi.org/10.1007/978-1-62703-026-7_22
Patent
Patent Granted. Title “A PHYTO-FORMULATION TO CONTRO L TICK INFESTATION IN ANIMALS AND METHOD THEREOF” Application Filed Application no. 202341081381. Patent no. 558374.
Review
Borah A and Srivastava A*. Impact of Extracellular Enzymes on Staphylococcus aureus Host Tissue Adaptation and Infection. APMIS Volume133, Issue1, January 2025 e13502 (*corresponding author) DOI: https://doi.org/10.1111/apm.13502 .
Pubmed Link
Pubmed Dr. Anand Srivastava
Google Scholar Link
https://scholar.google.co.in/citations?user=5bnHpccAAAAJ&hl=en
Current Lab Members:
PhD Students
Mood Rajitha
CSIR- SRF
IMSc. Systems Biology, Central University of Hyderabad.
Current Research Interest:
Understanding the molecular events in the feeding of ticks
Macha Vijay
ICMR- SRF
M. Pharma, JNTU, Hyderabad
Current Research Interest:
Identification and characterization of active molecules in selected Indian medicinal plant extracts with irritant and toxic properties on mosquitoes and ticks
Krishnagaanth Mohan Kumar
DBT-SRF
MSc Biochemistry, Bharathiyar University, Coimbatore, Tamilnadu
Current Research Interest:
Insights of immunomodulatory events at the tick host interface
Amar Prajapati
ICMR- SRF
M.Sc. Microbiology, Deen Dayal Upadhyaya Gorakhpur University, Gorakhpur
Current Research Interest:
Deciphering major kinases group (CMGC/CAMK) of Theileria annulata for identification of drug targets
Ritika Rajput
CSIR-UGC-SRF
M.Sc. Life Sciences, Chhatrapati Shahuji Maharaj University, Kanpur.
Current Research Interest:
Deciphering the Role of Theileria Parasite Effectors in Modulating Host Cell
Jashaswi Priyadarshini Jena
DBT-JRF
M.Sc. Biotechnology, Utkal University, Bhubaneswar
Current Research Interest:
Mechanism of Biofilms formation in S. aureus
Ph.D. Students Graduated
Dr. ARAVETI PRASANNA BABU (Graduated in 2022)
Inspire-PhD fellowship
M.Sc. Department of Biotechnology and Bioinformatics, Yogi Vemana University
Currently working as a Post-Doctoral Fellow at National Emerging Infectious Diseases Laboratories Institute, Boston University. Boston, United States
Dr. PRAJNA PARIMITA KAR (Graduated in 2023)
Inspire-PhD fellowship
M.Sc. Bioinformatics, Orissa University of Agriculture and Technology
Currently working as a Post-Doctoral Fellow at The National Institutes of Health, United States
Research Associate
Dr. Atlanta Borah
Research Associate-I
Ph.D Biotechnology, Institute of Advanced study in Science and Technology, Guwahati, Assam
Current Research Interests:
Characterization of CDK-Cyclin pair in Theileria annulata, Identification and characterization of plant derived compounds for bacterial biofilm inhibition
Project Fellow
Ms. Annie Okram
Project Associate-I
M.Sc. Lovely Professional University, Panjab
Current Research Interests:
Isolation of active molecules from Plant extracts
Ms. Vanditha Nukala
Project JRF
M.Sc. Biotechnology, Dayananda Sagar University, Bangalore
Current Research Interests:
Epigenetics in Theileria parasite
Lab Alumni
Dr. (Mrs) Soma Behera (Dec 2018- Mar 2020)
Research Associate-I
Ph.D. Dr. Reddy’s Institute of Life Sciences Biotechnology, University of Hyderabad
Currently working as a Post-Doctoral Fellow at Nashville, Tennessee, United States
Dr. Amit Kumar Sahu (June 2017- Aug 2018)
Research Associate-I
Ph.D. Parasitology, IVRI
Currently working as a Research Associate at ICFMD, Bhubaneswar
Dr. (Mrs) Mathu Varunan Shalu ( April 2017 April 2019)
Research Associate-I
Ph.D. University of Hyderabad
Dr. Anil Kumar Kotha ( Feb 2015-Dec 2015)
Research Associate-I
Ph.D. University of Hyderabad
Mr. ACHINTYA SANJU (Nov 2023-Sep 2024)
Project Associate-I
M.Sc. Microbiology, Central University of Haryana
Currently working as a Ph.D. scholar at Oita University, Japan
Mr. RAHUL YADAV
Project Associate-II
M.Sc. BIOCHEMISTRY VEER BAHADUR SINGH PURVANCHAL UNIVERSITY
Current Ph.D. scholar at Vellore Institute of Technology, Vellore, Tamil Nadu
Mr. Akshay Kuriakose
Project Associate-I
M.Sc. Life Science Central University of Tamilnadu
Currently working as Senior Research Associate Syngene International Limited
Mr. Shiga Nagaraju
Field Assistant
M.Sc. Microbiology, JNTU, Hyderabad
Ms. Rolly Kumari
Project Fellow
Ms. Swetha Murthy (Nov 2014- Feb 2016)
Project SRF
M. Phil Biotechnology, Bharatidasan university
Ms. Rakhi Harne (Dec 2014- Feb 2015)
Project Fellow
M.Sc. Biotechnology Institute of Bioinformatics and Biotechnology (IBB), University of Pune
Dr. (Mrs) Rinky Sharma Mukherji (2013-2014)
Project Fellow
M.VSc. Assam Agriculture University, Assam
Trainee
Ms. Deepika (Jan-June 2025)
M.Sc. Microbiology, Central University of Haryana, Haryana.
Ms. Saloni Pandey (Jan-June 2025)
M.Sc. Biotechnology VIT, Vellore
Ms. Narawade Mahima Ramesh (Oct- Nov 2024)
MV.Sc. College of Veterinary Sciences, Parbhani
Mr. Amit Lalwani (Jan-June 2023)
M.Sc. Microbiology, Barkatullah University, Bhopal
Current Research Interest:
PhD scholar- BITS PILANI HYDERABAD CAMPUS
Mr. Bharat Upadhyay (Jan-June 2022)
M.Sc. Biotechnology, Dr. Bhimrao Ambedkar University, Agra
Mr. ACHINTYA SANJU (Jan-June 2021)
M.Sc. Microbiology, Central University of Haryana, Haryana.
Currently working as a Ph.D. scholar at Oita University, Japan
Ms. A Sai Lakshmi Mahitha (Jan-May 2020)
M.Sc. Biotechnology, VIGNAN’S foundation for Science and Technology, Guntur
Ms. B. Bala Preedeba (June-July 2014)
M Sc., PG College of Arts and Science, Coimbatore
Ongoing projects
1. Evaluation of medicinal plant extracts for anti-tick activity and identification of active compounds Ministry of AYUSH, National Medicinal Plants Board (New Delhi, India) 2017-04 to 2020-04
Grant: R&D/TL-01/2017
2. Establishment of genome manipulation technology in Theileria parasite for identification of genes involved in transformation of host cell. 2019-2021
Grant: BT/PR17590/GET/119/271/2018
Completed project
Elucidation of mechanism(s) of transformation of host cells by Theileria annulata Science and Engineering Research Board (Delhi, India) 2017-03 to 2020-03
Grant: EMR/2015/001828/AS
National Institute of Animal Biotechnology
Survey No. 37, Opp. Journalist Colony
Extended Q City Road, Near Gowlidoddy
Gachibowli, Hyderabad
Telangana – 500032
Email: anand[at]niab[dot]org[dot]in
Tel: +91 40 2312 0141
My lab is currently open for the motivated and hardworking research scholars and post-doctoral researchers.
For PhD position: If you have NET-JRF and you are interested in my research areas you may contact me for further discussion.
For Post-doctoral position: If you have new ideas which is the lines with my lab interest kindly contact me for discussion for applying to various granting agency for fellowship.
All the available positions in extramural grants are displayed on the NIAB website.
An Autonomous Institute of the Department of Biotechnology,
Ministry of Science and Technology, Government of India
+91 40 2312 0103
admin[at]niab[dot]org[dot]in
© National Institute of Animal Biotechnology (NIAB)
Made with ❤ by NIAB